Dose-Ranging Trial of Safety & Immunogenicity of an Oral Adenoviral-Vector Based RSV Vaccine (VXA-RSV-f)

Clinical trial NCT02830932 · COMPLETED

Trial details

NCT number: NCT02830932
Sponsor: Vaxart
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Respiratory Syncytial Virus (RSV)

Start date: 2016-06-22
Primary completion: 2016-09-16
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.